|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/12 | (2006.01) |
| A61K | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 31/57 | (2006.01) | ||
| A61K 47/06 | (2006.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/34 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 1073417 |
| (13) | Kind of document | T |
| (96) | European patent application number | 99916921.2 |
| Date of filing the European patent application | 1999-04-15 | |
| (97) | Date of publication of the European application | 2001-02-07 |
| (45) | Date of publication and mention of the grant of the patent | 2002-12-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP9902/535 |
| Date | 1999-04-15 |
| (87) | Number | WO 9905/3901 |
| Date | 1999-10-28 |
| (30) | Number | Date | Country code |
| 9808152 | 1998-04-18 | GB | |
| 9814709 | 1998-07-08 | GB |
| (72) |
CAVAILLON, P., Lab. Glaxo Wellcome, Zone Ind. no2, FR
LLORCA, N., Lab. Glaxo Wellcome, Zone Ind. no2, FR
LOUIS, O., Lab. Glaxo Wellcome, Zone Ind. No 2, FR
ROSIER, P., Lab. Glaxo Wellcome, Zone Ind. no. 2, FR
|
| (73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 0NN,
GB
|
| (54) | PHARMACEUTICAL AEROSOL FORMULATION |
| PHARMACEUTICAL AEROSOL FORMULATION |